Related by context. All words. (Click for frequent words.) 72 ZALBIN 68 LymphoStat B 68 Icatibant 68 albinterferon alfa 2b 67 ATryn ® 67 Biologics License Application 67 JOULFERON 67 Zalbin 66 ATryn R 65 Preotact 65 Rhucin ® 65 NEBIDO 65 BENLYSTA ® 65 Clolar 65 Plenaxis TM 65 Civacir 65 Zingo TM 65 REPLAGAL 65 ambrisentan 65 Joulferon 65 Zelrix 64 Marketing Authorization Applications 64 FOLOTYN 64 fidaxomicin 64 Marketing Authorization Application 64 SEBIVO 64 SUMAVEL DosePro 64 forodesine 64 Nebido 64 Alvesco R 64 Ruconest 64 Nexavar ® 64 ORENCIA R 64 Zavesca r 64 Acetavance 64 eltrombopag 64 Increlex R 63 clofarabine 63 vilazodone 63 FIRAZYR 63 MEPACT 63 BLA filing 63 topical NSAID 63 PREOS R 63 Kuvan 63 THALOMID 63 Ceplene 63 ADVEXIN 63 Rhucin 63 Oracea 63 VPRIV 63 TREANDA 63 Flutiform TM 63 Campath ® 63 Certican 63 OFIRMEV 63 Biologic License Application BLA 63 BEMA Fentanyl 63 Restanza 63 ezogabine 63 alvimopan 63 Somatuline Depot 62 OMP designation 62 Plicera 62 ONTAK 62 Loramyc ® 62 Firazyr 62 Cellegesic 62 Soliris TM eculizumab 62 Jevtana 62 velaglucerase alfa 62 Increlex ® 62 Benlysta belimumab 62 Biologics License Application BLA 62 ZADAXIN 62 Nabi HB Intravenous 62 SYCREST 62 BYETTA ® 62 Raptiva ® 62 Allovectin 7 R 62 Reverset 62 Replagal 62 Zebinix R 62 ELAPRASE 62 prGCD 62 refractory Hodgkin lymphoma 62 Naglazyme 62 UPLYSO 62 Loramyc R 62 Ceflatonin 62 Sebivo 62 diabetic neuropathic pain 62 PLK1 SNALP 62 sBLA 62 HuMax CD4 62 Fortigel 62 orphan designation 62 Phenoptin 62 valopicitabine 62 Bronchitol 62 Actemra tocilizumab 62 CUBICIN 62 StaphVAX 62 Advexin 62 taliglucerase alfa 62 YONDELIS 62 INCB# [002] 62 Antegren 62 Azilect ® 62 maribavir 62 Traficet EN 61 Orphan Drug designation 61 Raptiva R 61 MAA submission 61 supplemental Biologics License Application 61 vosaroxin 61 forodesine hydrochloride 61 MONOVISC 61 orphan medicinal product 61 Adenuric R 61 Cinryze 61 Anthim 61 Clofarabine 61 Cimzia ® 61 Increlex 61 Plenaxis R 61 Clevudine 61 RAPAFLO 61 Evoltra ® 61 pralatrexate 61 Amigal 61 Clolar ® 61 Orphan Drug designations 61 Vidaza 61 ruxolitinib 61 Advagraf 61 Qutenza 61 ixabepilone 61 Surfaxin LS 61 tamibarotene 61 QAB# 61 Satraplatin 61 CYCLOSET 61 Marketing Authorisation Application 61 thymalfasin 61 satraplatin 61 ONSOLIS 61 Strativa 61 Fodosine 61 Rebif ® 61 acyclovir Lauriad R 61 IV APAP 61 omacetaxine 61 VIDAZA 61 INCB# [001] 61 talactoferrin 61 pitavastatin 61 Corlux 61 Exalgo 61 Folotyn 61 highly purified pasteurized 61 telbivudine 61 Dificid 61 Phase IIIb clinical 61 AZILECT R 61 Allovectin 7 ® 61 Esbriet 60 TYZEKA 60 EGRIFTA TM 60 Treanda 60 Japanese Encephalitis vaccine 60 ZOSTAVAX 60 Stelara 60 European Medicines Evaluation 60 IRESSA 60 cinacalcet HCl 60 Archexin 60 Voraxaze ™ 60 Zytiga 60 SUMAVEL 60 COLAZAL 60 Dyloject 60 Synvisc One 60 GTC recombinant human 60 methylnaltrexone 60 Evoltra 60 Elagolix 60 Leukine 60 Actemra 60 Cladribine Tablets 60 balsalazide tablet 60 TOCOSOL Paclitaxel 60 Tostrex 60 Alzhemed TM 60 Extavia 60 Bepreve 60 Orapred ODT 60 Application BLA 60 tezampanel 60 Azedra TM 60 FACTIVE tablets 60 Loramyc 60 Numax 60 Saphris 60 Panzem R NCD 60 raxibacumab 60 EOquin 60 TRISENOX 60 PREOS 60 XIAFLEX 60 Mepact 60 Marqibo 60 Belimumab 60 ecallantide 60 Somatuline R Autogel R 60 Amrubicin 60 Filgrastim 60 ROTATEQ 60 ZEGERID Capsules 60 SNT MC# 60 Dacogen injection 60 Q#IR 60 Evoltra TM 60 Fortical R 60 Marketing Authorization Application MAA 60 torezolid phosphate 60 IMA# 60 TBC# 60 Lupuzor 60 Multiferon R 60 rThrombin 60 registrational 60 vemurafenib 60 tesetaxel 60 Vasovist 60 mifamurtide 60 Ranexa 60 OLEPTRO TM 60 ospemifene 60 Riquent 60 NPSP# 60 TEMODAL 60 OPAXIO 60 ITAX 60 Cladribine 60 oral ridaforolimus 60 sapacitabine 60 dalbavancin 60 INT# [002] 60 Onco TCS 60 RAPTIVA 60 Phase IIb trials 60 IIa trial 60 Ceplene R 60 ZADAXIN ® 59 Promacta 59 Dyloject TM 59 Evoltra R 59 FACTIVE 59 Firdapse 59 EGRIFTA ™ 59 oral fludarabine 59 maraviroc 59 LymphoStat B belimumab 59 Medicinal Products EMEA 59 AP# [003] 59 Pirfenidone 59 XIAFLEX TM 59 Reclast Aclasta 59 L MTP PE 59 CoFactor 59 Exforge 59 BYDUREON 59 Rhucin R 59 Emselex 59 FUSILEV 59 Hycamtin 59 Ventavis 59 BEXXAR 59 ozarelix 59 alvespimycin 59 Torisel 59 COMFORT II 59 JANUVIA 59 OvaRex ® MAb 59 Albuferon 59 Targretin capsules 59 ZEFTERA TM Zevtera TM 59 candidate epratuzumab 59 registrational trial 59 Complete Response 59 PANVAC VF 59 LIVALO 59 PROMACTA 59 Vilazodone 59 celgosivir 59 ONGLYZA ™ 59 sunitinib malate 59 telaprevir 59 KNS # 59 Orphan Drug Designation 59 Actimmune ® 59 carfilzomib 59 Allovectin 7 59 Taxotere ® 59 elotuzumab 59 Locteron 59 tocilizumab 59 Zenpep 59 MEZAVANT 59 amrubicin 59 Chemophase 59 Orphan Medicinal Product 59 MoxDuo IR 59 alogliptin 59 RhuDex ® 59 REMICADE ® 59 molecular entities NMEs 59 BENLYSTA TM 59 Somatuline R Depot 59 Lialda 59 linaclotide 59 confirmatory Phase III 59 SILENOR 59 ABILIFY R 59 phase IIa clinical 59 Abstral 59 SEROQUEL XR 59 Xyrem ® 59 Daliresp 59 ApoB SNALP 59 Mozobil 59 Genasense 59 refractory chronic lymphocytic 59 EndoTAG TM -1 59 OMAPRO 59 axitinib 59 PROVENGE ® 59 sNDA filing 59 R sorafenib tablets 59 oral taxane 59 TELINTRA 59 Junovan 59 Aloxi R 59 metaglidasen 59 atacicept 59 EFAPROXYN 59 ALGRX 59 eniluracil 59 Rasagiline 59 Vandetanib 59 Gleevec Glivec 59 asenapine 59 zileuton CR 59 MOZOBIL 59 TYKERB 59 biogeneric 59 tafamidis 59 Onbrez Breezhaler 59 LUVENIQ 59 Orphan Drug status 59 GALNS 59 QVAR 59 SIMPONI 59 IMGN# 59 ponatinib 59 AMITIZA R 59 ISENTRESS 59 oral methylnaltrexone 59 ELADUR 59 PrevOnco ™ 59 Intermezzo R 59 HQK 59 CIMZIA TM 58 Octreolin 58 SILENOR TM 58 eprodisate KIACTA TM 58 HuMax CD# 58 Aphthasol R 58 mipomersen 58 perifosine 58 LEUKINE 58 formerly LymphoStat B 58 orBec 58 Ixempra 58 Zerenex 58 NUVIGIL 58 AzaSite Plus 58 Aryplase 58 R#/MEM # 58 decitabine 58 JAK inhibitor 58 pomalidomide 58 panitumumab 58 tezampanel NGX# 58 Cinryze TM 58 TRANSDUR Sufentanil 58 lumiliximab 58 Orencia 58 ORENCIA ® 58 Exelbine 58 PEG PAL 58 MabCampath 58 lasofoxifene 58 BLA submission 58 pegylated interferon alpha 58 ustekinumab 58 Cimzia 58 Telatinib 58 Treximet 58 deforolimus 58 RELISTOR ® 58 ridaforolimus 58 BEMA Buprenorphine 58 faropenem 58 Pivotal Phase III 58 XIAFLEX ™ 58 INTEGRILIN R eptifibatide Injection 58 glucokinase activator 58 ZETIA 58 ISENTRESS raltegravir 58 NeoVisc 58 Serdaxin 58 anti TNF alpha 58 Cethrin 58 Orphan Drug Status 58 Angiox 58 MGCD# [001] 58 ONCONASE 58 CONBRIZA 58 Roche PEGASYS R 58 Stedivaze 58 pirfenidone 58 CAELYX 58 Arzerra ofatumumab 58 casopitant 58 NDA submission 58 ketolide antibiotic 58 Omigard TM 58 bifeprunox 58 Firazyr ® 58 iloperidone 58 indacaterol 58 ganetespib 58 CORLUX 58 vernakalant iv 58 StaphVAX R 58 FOSRENOL 58 DIFICID 58 Mycamine 58 HCV protease inhibitor 58 SUTENT 58 LymphoStat B TM 58 SURFAXIN 58 Androxal ® 58 IV acetaminophen 58 fostamatinib 58 Vertex telaprevir 58 bazedoxifene 58 Troxatyl 58 Eloxatin ® 58 MabThera Rituxan 58 Zenvia ™ 58 Nimotuzumab 58 interferon beta 1b 58 Gemzar ® 58 Pennsaid 58 Nexavar sorafenib 58 Onsolis 58 Tarceva erlotinib 58 Fabry Disease 58 Valtropin 58 chronic angina 58 apaziquone 58 briakinumab 58 Argatroban 58 Sprycel dasatinib 58 vidofludimus 58 L BLP# 58 pegloticase 58 tramiprosate ALZHEMED TM 58 Sanctura XR 58 Xolegel 58 Genz # 58 Aurexis 58 octreotide implant 58 Cimzia R 58 OncoVEX GM CSF 58 teduglutide 58 sorafenib tablets 58 LEVADEX ™ 58 Cloretazine ® 58 MethyPatch 58 Mipomersen 58 OSMOPREP 58 Biologics Licensing 58 metoprolol succinate 58 Visudyne R 58 drug ISA# 58 ZEVALIN 58 supplemental biologics 58 Proxinium TM 58 vernakalant oral 58 Telaprevir 58 PROVIGIL 58 Afinitor 58 ANDA filings 58 Azedra 58 daily tramadol 58 dirucotide 58 oxymorphone ER 58 Ophena TM 58 T Pred 58 HUMIRA 58 lymphoma CTCL 58 Tracleer r 58 KALBITOR ® 58 UCB Cimzia 58 phase IIb clinical 58 FDA approvable letter 58 sumatriptan DosePro 58 Onalta ™ 58 Victrelis 58 Cubicin 58 PEG Interferon lambda 58 Tarceva TM 58 XmAb# 58 incyclinide 58 Arranon 58 ofatumumab 58 Eligard ® 58 AzaSite 58 Acetavance TM 58 Eligard R 58 regadenoson 58 BEMA TM Fentanyl 58 FlutiformTM 58 Rotarix R 58 intravenous acetaminophen 58 peginesatide 58 Movectro 58 PhosLo 58 polymer platinate 58 liprotamase 58 severe hypercholesterolemia 58 amifampridine phosphate 58 PEG interferon 58 5 lipoxygenase inhibitor 58 successfully commercialize Iluvien 57 Omigard 57 Soriatane 57 Benlysta 57 Phase 2b trial 57 tanespimycin 57 Bicifadine 57 Entereg 57 Solzira 57 Abraxane 57 YONDELIS R 57 pradefovir 57 CHMP recommendation 57 Onalta 57 Fludara 57 Virulizin R 57 RANK Ligand inhibitor 57 Arzerra 57 Tamibarotene 57 Oracea TM 57 STELARA 57 NEBIDO R 57 rALLy clinical trial 57 epigenetic therapies 57 aztreonam lysine 57 ACTEMRA 57 RG# [001] 57 heterozygous FH 57 Lucanix R 57 canakinumab 57 Fampridine SR 57 Shigamabs ® 57 RELISTOR 57 azacitidine 57 Teflaro 57 vandetanib 57 bicifadine 57 Helsinn Healthcare 57 ONCASPAR 57 tivozanib 57 NVA# 57 Ambrisentan 57 CCR9 antagonist 57 IMVAMUNE R 57 Rasilez 57 PXD# 57 RoACTEMRA 57 Milnacipran 57 novel histone deacetylase 57 cutaneous T cell 57 Serdolect ® 57 Velac 57 liver resection surgeries 57 Orathecin 57 DPP4 inhibitor 57 SANCTURA XR 57 Panzem R 57 Asentar 57 Etanercept 57 GATTEX 57 Feraheme 57 Somatuline Autogel 57 DAVANAT R 57 PRTX 57 TYSABRI 57 Relistor 57 Increlex TM 57 MAXY alpha 57 rasagiline tablets 57 FDA Approvable Letter 57 Zevtera 57 Marketing Authorization 57 TAXUS Element Stent System 57 XIAPEX 57 ASONEP 57 HEPLISAV 57 Invicorp R 57 ANTEGREN 57 Modrenal R 57 Dasatinib 57 rhC1INH 57 RITUXAN 57 VYVANSE 57 Arcalyst 57 Solasia 57 Dapagliflozin 57 ELIQUIS 57 MBP# [001] 57 Centralized Procedure 57 Oncophage 57 oral prodrug 57 TELCYTA 57 Campath 57 Ceflatonin R 57 FACTIVE R gemifloxacin 57 Erbitux cetuximab 57 Santhera 57 Neurodex 57 FROVA 57 DXL# 57 Dendreon Provenge 57 Lipofen 57 Amevive 57 Altastaph 57 Kalbitor 57 INC# 57 Azixa 57 AEG# 57 VALSTAR 57 RECOTHROM R 57 Fanapt TM 57 ARIKACE 57 AnGes 57 YERVOY 57 Phase III pivotal 57 Ranexa R 57 Maraviroc 57 dasatinib Sprycel ® 57 Fenoglide 57 pseudobulbar affect PBA 57 Marketing Authorisation Application MAA 57 Dalbavancin 57 trabectedin 57 MOVIPREP R 57 Zadaxin 57 AERx iDMS 57 orphan drug 57 low dose cytarabine 57 BiovaxID 57 RAPTIVA R 57 bardoxolone 57 Taxotere R 57 Dynepo 57 Loramyc ™ 57 FDA Orphan Drug 57 Viramidine 57 Eribulin 57 anti EGFR antibody 57 Herceptin trastuzumab 57 DAVANAT ® 57 FIRMAGON R 57 MuGard 57 Phase IIB 57 Clavis Pharma 57 nitazoxanide 57 Alvesco 57 CIMZIA ™ 57 CytoFab 57 Orphan Designation 57 metastatic renal cell 57 BCX# 57 HepeX B 57 MAGE A3 ASCI 57 methylnaltrexone bromide 57 PNP inhibitor 57 Diamyd ® 57 BAY #-# 57 biosimilar 57 virus HCV protease inhibitor 57 ENRICH trial 57 Renvela 57 HoFH 57 leading oral taxane 57 Phase III clinical trials 57 belimumab 57 OMNARIS Nasal Spray 57 receptor tyrosine kinase inhibitor 57 GAMMAGARD 57 Exenatide LAR 57 Krystexxa 57 Biological License Application 57 ofatumumab HuMax CD# 57 rhThrombin 57 Uplyso 57 Neulasta R 57 Aegerion 57 orBec R 57 VIVITROL ® 57 Syncria 57 Imvamune 57 Golimumab 57 Trexima 57 Kamada AAT 57 Catena ® 57 Onconase 57 alefacept 57 OMNARIS HFA 57 BioSTAR R 57 crofelemer 57 TNF alpha inhibitor 57 NGX# 57 Frova ® 57 CytoFabTM 57 enzastaurin 57 Besivance 57 ALN PCS 57 fluoroquinolone antibiotic 57 Glybera R 57 Multikine 57 Silenor ® 57 Visian Toric ICL 57 Keppra ® XR 57 Vidaza R 57 Prestara TM 57 novel VDA molecule 57 ASA# 57 lurasidone 57 Ruconest ™ 57 FLECTOR ® Patch 57 Ketotransdel 57 ATL# [001] 57 Orexo 57 therapeutic monoclonal antibodies 57 PDUFA date 57 refractory APL 56 Proquin XR 56 Eli Lilly Cymbalta 56 application sNDA 56 non metastatic osteosarcoma 56 Multaq R 56 XAGRID 56 RIGScan CR 56 Polyphenon ® E 56 Macroplastique 56 mesylate tablets 56 otelixizumab 56 lubiprostone 56 proprietary transdermal patch 56 SUPPRELIN LA 56 PROVENGE sipuleucel T 56 Esbriet pirfenidone 56 sNDA 56 phase IIa 56 Fibrillex TM 56 Hectorol R 56 CDP# 56 BCR ABL inhibitor 56 Ciclesonide 56 nalbuphine ER 56 Neuromodulation System 56 CCR5 mAb 56 Stimuvax R 56 HuCAL antibodies 56 Rescula 56 Oncaspar 56 registrational studies 56 T DM1 56 NOXAFIL 56 Clonicel 56 daclizumab 56 Inhalation Solution 56 ZOLINZA 56 Personalized Immunotherapy 56 KYNAPID 56 STELARA TM 56 AVASTIN 56 GEM #S 56 systemic ALCL 56 Prednisporin TM 56 FUSILEV ® 56 lomitapide 56 refractory PTCL 56 Oncoscience AG 56 Yervoy 56 Glassia 56 Vectibix panitumumab 56 Mylotarg 56 AZILECT ® 56 Serdolect 56 silodosin 56 ACTEMRA TM 56 Fludara ® 56 budesonide foam 56 Zanaflex Capsules 56 AMITIZA ® 56 APF# 56 HGS# 56 PRX # 56 ARCOXIA 56 roflumilast 56 Galvus 56 Viviant 56 TRANSDUR Bupivacaine 56 Frova R 56 NDA resubmission 56 NMEs 56 Qutenza TM 56 Zenvia 56 autoimmune indications 56 rALLy 56 MYDICAR ® 56 Vectibix 56 Sprycel 56 BRILINTA 56 Afinitor ® 56 Soliris eculizumab 56 AeroLEF TM 56 Uvidem 56 ACZ# 56 Canvaxin 56 oral FTY# 56 SinuNase 56 ALVESCO R 56 BARACLUDE R 56 Genasense ® 56 FavId 56 Priority Review 56 Phase III HEAT 56 sNDA submission 56 Sulonex TM 56 Multiferon ® 56 Cethromycin 56 ceftaroline 56 HCD# [002] 56 Velcade bortezomib 56 lupus nephritis 56 CNTO 56 ZENPEP 56 Camvia 56 GATTEX TM 56 Sancuso 56 AVINZA 56 relapsed refractory multiple myeloma 56 Prestara 56 SCHWARZ PHARMA 56 Dacogen 56 CLIA waiver 56 Phase Ib study 56 REBETOL combination therapy 56 ProSavin 56 DORIBAX 56 KALBITOR 56 voclosporin 56 pancreatic enzyme replacement 56 cardio renal 56 QNEXA 56 ATryn 56 alglucosidase alfa 56 LibiGel ® 56 Rotarix ® 56 CAMPATH 56 Ilaris 56 Oracea ® 56 RDEA# 56 Cimzia ® certolizumab pegol 56 CHMP opinion 56 Ethyol 56 ATL/TV# 56 rilonacept 56 glufosfamide 56 oncology indications 56 abiraterone acetate 56 gepirone ER 56 IND submission 56 Camptosar 56 Market Authorization Application 56 Pruvel 56 Onrigin 56 denufosol 56 omacetaxine mepesuccinate 56 RSR# 56 compound INCB# 56 TACI Ig 56 IMiDs 56 dirucotide MBP# 56 bosutinib 56 Doribax 56 oral proteasome inhibitor 56 Protexia ® 56 Moxatag 56 MYDICAR 56 indiplon capsules 56 TriLipix 56 Betaferon 56 Eliquis 56 Vivitrex 56 trastuzumab DM1 T DM1 56 NovaDel 56 GLASSIA 56 registrational trials 56 Pradefovir 56 AMPYRA 56 desvenlafaxine 56 Desmoteplase 56 Pegasys peginterferon alfa 2a 56 Eloxatin R 56 Rectogesic 56 Aviptadil 56 Amigal TM 56 DepoDur TM 56 DIFICID ™ 56 MDV# 56 tasocitinib 56 Sylvie Gregoire President 56 Aloxi injection 56 Thelin tm 56 TREDAPTIVE 56 equine osteoarthritis 56 LIALDA 56 Sudhir Agrawal D.Phil 56 forodesine HCl 56 XL# [003] 56 romiplostim 56 senicapoc 56 adalimumab 56 Theratope 56 REYATAZ R 56 retigabine 56 Orencia abatacept 56 RAPTIVA r 56 Phase IIa trials 56 Veronate 56 FTY# 56 Arixtra 56 Rebif R 56 Tasimelteon 56 Lumacan 56 Fusilev 56 Telzir 56 Tracleer R 56 PHX# 56 Istalol 56 subcutaneous formulation 56 recombinant biopharmaceutical 56 Fanapt iloperidone 56 Valortim 56 Orphan designation 56 MNTX 56 SPRYCEL ® 56 HuLuc# 56 Aptivus 56 Ceplene ® 56 Roflumilast 56 confirmatory Phase 3 56 tipranavir 56 AMEVIVE 56 Xifaxan 56 dextromethorphan quinidine 56 dimebon 56 Preotact R 56 REMINYL ® 56 Urocidin 56 Tekamlo 56 Phase #b/#a clinical 56 romidepsin 56 ACOMPLIA R 56 Silenor ® doxepin 56 Tygacil 56 nebivolol 56 RSD# 56 ARIKACE ™